12/1/2009 6:13 PM ET

RELATED NEWS Dyax To Present At The BIO CEO & Investor Conference; Webcast At 10:30 AM ET Dyax Gets FDA Approval For Genetic Disorder Drug - Stocks To Watch Dyax Receives FDA Nod For Genetic Disorder Treatment Kalbitor - Update Dyax Gets FDA Approval For Kalbitor To Treat Acute Attacks Of Hereditary Angioedema - Quick Facts Trade DYAX now with

Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print           Follow Us   

Top Stories UDR Q4 FFO Declines; Guides FY10 Baidu Q4 Profit Up 48.2%; Guides Q1 Revenue Above Estimates IMS Health Q4 Profit Declines 27% CareFusion Q2 Profit Declines; Revises Up FY10 View - Update Cerner Q4 Profit Declines, Yet Tops View - Update

Earnings Axia NetMedia Q2 Profit Declines - Quick Facts RenaissanceRe Holdings Swings To Profit In Q4 - Update Aspen Insurance Holdings Q4 Profit Surges, Tops View - Update Gildan Activewear Q1 Profit Surges; Backs FY10 Outlook - Update Max Capital Group Swings To Q4 Profit - Update

US Market Commentary Stocks Post Strong Gains Amid Prospective Greece Bailout - U.S. Commentary Stocks Hovering Near Highs In Mid-Afternoon Trading - U.S. Commentary TSX Jumps On Greece Rescue Rumors Stocks Building On Strong Gains In Early Afternoon Trading - U.S. Commentary Stocks Give Back Ground But Remain Mostly Higher - U.S. Commentary

US Economic News Reports: Germany Yet To Decide On Possible Aid Package To Greece Bernanke Hearing Postponed Due To Weather Wholesale Inventories Show Unexpected Decrease In December Wholesale Inventories Fell 0.8% In December Small Business Optimism Shows Slight Improvement In January

Political News Obama: International Community Moving Quickly Towards Iran Sanctions Obama Calls For Give And Take With GOP EU Parliament Approves New European Commission Rubio Endorsed By Conservative Leader In Florida Senate Primary Washington Snowstorm Forces House To Cancel Votes For Rest Of Week